In addition, efforts made by Janssen in terms of environmental care were rewarded during the successful ISO14001 and OHSAS 18001 follow-up audit of the environment, safety and healthcare system in March 2013. 

These audits do not only verify compliance with the regulations, but must also demonstrate a continuous improvement of the environmental, health and safety performance. No serious or less serious shortcoming was detected in the care system. 

Besides this audit, Janssen was also subjected to 27 other audits and inspections, performed by several external organizations, including the government.  


For Janssen, ecological sustainability starts from the development of new products, with the application of green chemistry and green technology.

During the production of our medicines, we aim to continuously improve our environmental performance. At the end of the life cycle of our medicines, we take a careful and responsible line in this context.

In this broad field of action, we aim to reduce our ecological footprint as much as possible: fewer raw materials, efficient production through reduced water and energy consumption, and production of less waste and emissions.

This leads to a win-win situation: Janssen minimizes its impact on the environment from the outset, while, at the same time, saving a lot of time and money in the long run.